Congratulations, you have now completed this module. Your e-certificate is available for download from the main menu.
Congratulations, you have completed the module. Please click [Close] button to exit.
Introduction to mainstream genetic testing
What is mainstream genetic testing?
Why offer mainstream genetic testing?
Who can perform mainstream genetic testing?
How genetic testing can guide treatment decisions
Fundamentals of genetics
Overview of genetics terminology
Classification of gene variants
Hereditary and acquired gene variants
Pathogenic variants and disease
Overview of genetic testing
Pathogenic variants in patients with breast and ovarian cancer
BRCA testing: overview
Eligibility criteria for genetic testing in patients with breast and ovarian cancer
Medicare-funded genetic testing for pathogenic BRCA1 and BRCA2 gene variants in patients with breast and ovarian cancer
Identification of a pathogenic or likely pathogenic variant
The mainstream genetic testing process – overview
Tools and resources to support mainstream genetic testing
Localising tools and resources to support mainstream genetic testing
The mainstream genetic testing process
Four main parts to mainstream genetic testing
1. Assess that the patient meets eligibility criteria for Medicare-funded genetic testing2. Introduce mainstream genetic testing, consent patients for testing and organise the test3. Receiving, interpreting and giving genetic test results4. Referral to the local FCC/genetics service
Questions patients may ask during the mainstream genetic testing process